RE-BVS – Piemonte Repository

Sfoglia per AUTORE
EFFICACE F
Collezione AOU Novara

Items : 6

Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System. in JCO oncology practice / JCO Oncol Pract. 2024 Mar;20(3):438-447. doi: 10.1200/OP.23.00434. Epub 2024 Jan 11.

2024
AO Ordine Mauriziano
AOU Novara

Fazi P; Platzbecker U; Luppi M; Baron F; Di Maio M; Perrone F; Venditti A; Voso MT; Brini A; Cavo M; Anota A; Gaidano G; Giesinger JM; Sparano F; Vignetti M; Efficace F;

Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia. in Cancer / Cancer. 2024 Jan;130(2):287-299. doi: 10.1002/cncr.35021. Epub 2023 Oct 6.

2024
AOU Città della Salute di Torino
AOU Novara

Cella D; Vignetti M; Cortes J; Rosti G; Dinner S; Altman JK; Abruzzese E; Fava C; Iurlo A; Giai V; Luciano L; Tiribelli M; Breccia M; Miggiano MC; Patriarca A; Capodanno I; Bonifacio M; Caocci G; Castagnetti F; Kota V; Yanez B; Cottone F; Efficace F;

Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial. in Blood / Blood. 2024 Aug 1;144(5):541-551. doi: 10.1182/blood.2023023625.

2024
AOU Città della Salute di Torino
AOU Novara

Fazi P; Mengarelli A; Legrand O; Baron F; Candoni A; Posthuma EFM; Vrhovac R; Venditti A; Gaidano G; Crysandt M; Fuhrmann S; Foà R; Audisio E; Luppi M; Neubauer A; Griskevicius L; Chantepie S; Noppeney R; van der Velden WJFM; Coens C; Suciu S; Kicinski M; Efficace F; Vignetti M; Giraut A; Wijermans PW; Huls G; Lübbert M;

10-day decitabine versus 3?+?7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial. in The Lancet. Haematology / Lancet Haematol. 2023 Nov;10(11):e879-e889. doi: 10.1016/S2352-3026(23)00273-9.

2023
AOU Città della Salute di Torino
AOU Novara

Becker H; Blijlevens N; Wäsch R; Vilque JP; Ammatuna E; Efficace F; de Graaf AO; Stevens-Kroef M; Jansen JH; Hoogendoorn M; Giraut A; Posthuma EFM; van Lammeren-Venema D; Gaidano G; Foà R; Legrand O; Candoni A; Audisio E; Fuhrmann S; Luppi M; Vrhovac R; Crysandt M; Neubauer A; Griškevi?ius L; Noppeney R; Van der Velden WJFM; Chantepie S; Kicinski M; Wijermans PW; et alii...

Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia. in Leukemia & lymphoma / Leuk Lymphoma. 2021 Mar;62(3):669-678. doi: 10.1080/10428194.2020.1838509. Epub 2020 Nov 6.

2021
AOU Novara

Rosti G; Castagnetti F; Baccarani M; Vignetti M; Di Renzo N; Sorà F; Miggiano MC; Saussele S; Sztankay M; Albano F; Kota V; Oerlemans S; Cascavilla N; Okumura I; Breccia M; Cottone F; Abruzzese E; Wan C; Caocci G; Blijlevens NMA; Capodanno I; Elena C; Bonifacio M; Ector G; Stagno F; Bee PC; Patriarca A; Efficace F; Iurlo A; et alii...

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy. in Leukemia / Leukemia. 2020 Feb;34(2):488-498. doi: 10.1038/s41375-019-0563-0. Epub 2019 Sep 2.

2020
AOU Città della Salute di Torino
AOU Novara

Rosti G; Binotto G; Vignetti M; Bergamaschi M; Fozza C; Cascavilla N; Saussele S; Pregno P; Gozzini A; Patriarca A; Capodanno I; Martino B; Tiribelli M; Crugnola M; Caocci G; Castagnetti F; Abruzzese E; Cottone F; Bonifacio M; Breccia M; Iurlo A; Efficace F; Stagno F;